Ajinomoto acquires Norgine product for Japan
This article was originally published in Scrip
Executive Summary
Norginehas granted Ajinomotoexclusive Japanese development, manufacturing and marketing rights to its prescription bowel cleansing product Moviprep. Financial details of the transaction, Norgine's first for the Japanese market, were not disclosed. The product is used prior to colonoscopy and other procedures and is already marketed by Norgine in Europe and Salix Pharmaceuticals in the US. Ajinomoto, a diversified foods group, already markets a similar intestinal cleansing solution, Niflec, in its home market.